41 results
6-K
RDHL
Redhill Biopharma Ltd.
10 Nov 22
Current report (foreign)
4:23pm
granted to it to secure such indebtedness, which would have a material adverse effect on our reputation, business, financial condition or results … such transactions could harm our reputation in the investment and commercial community and result in a decline in the market price of the ADSs. Additionally, if we
424B5
RDHL
Redhill Biopharma Ltd.
22 Nov 21
Prospectus supplement for primary offering
4:30pm
to exclude others using proprietary rights could have a material adverse effect on our reputation, business, financial condition or results … of applicable drug promotion requirements, or prohibitions, could harm our business and our reputation, as well as the reputation of any approved drug
424B5
o2hv2mkxvfvxw
18 Nov 21
Prospectus supplement for primary offering
4:17pm
424B5
hhwt gg688z
3 Mar 21
Prospectus supplement for primary offering
4:31pm
424B5
rmdhgf5 w7u
1 Mar 21
Prospectus supplement for primary offering
4:56pm
424B5
sekjcb 9ho
13 Jan 21
Prospectus supplement for primary offering
5:09pm
424B5
eup rq1u4z8nc6h
11 Jan 21
Prospectus supplement for primary offering
4:47pm
F-3
bl3kunsplfac7jjijf0m
24 Jul 19
Shelf registration (foreign)
7:03am
424B5
jtzr9 h1jwb
23 Jul 19
Prospectus supplement for primary offering
8:31am
6-K
EX-2
e3twqliqcs1 xkzl3pc
7 May 19
Current report (foreign)
7:01am
424B5
0sw5 bx927in5yx6y
10 Dec 18
Prospectus supplement for primary offering
12:03pm
424B5
ag7 9htsflr
4 Dec 18
Prospectus supplement for primary offering
4:05pm